Embla Medical hf. (CPH:EMBLA)
Denmark · Delayed Price · Currency is DKK 26.45
-0.55 (-2.04%)
Jul 8, 2026, 4:59 PM CET
Embla Medical Market Cap
Embla Medical has a market cap or net worth of 11.51 billion as of July 8, 2026. Its market cap has decreased by -19.84% in one year.
Market Cap
11.51B
Enterprise Value
14.52B
Revenue
6.21B
Ranking
n/a
PE Ratio
20.66
Stock Price
26.45
Market Cap Chart
Since September 4, 2009, Embla Medical's market cap has increased from 2.33B to 11.51B, an increase of 394.76%. That is a compound annual growth rate of 9.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 11.51B | -17.12% |
| Dec 30, 2025 | 13.89B | -8.62% |
| Dec 30, 2024 | 15.20B | 31.74% |
| Dec 29, 2023 | 11.54B | -18.15% |
| Dec 30, 2022 | 14.10B | -21.07% |
| Dec 30, 2021 | 17.86B | -12.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.42T |
| Genmab | 112.20B |
| Coloplast | 89.53B |
| Demant | 59.30B |
| H. Lundbeck | 41.40B |
| Zealand Pharma | 21.12B |
| Ambu A/S | 17.61B |
| Bavarian Nordic | 14.55B |